SonoThera bags $125M series B to advance safer gene therapies
BioSpace
Instead of using viral vectors, SonoThera's genetic medicines are delivered through an ultrasound-mediated technology that could help sidestep key safety issues with conventional delivery methods.
pharminent
June 11, 2026 (Last updated: June 15, 2026)
BioSpace
Instead of using viral vectors, SonoThera’s genetic medicines are delivered through an ultrasound-mediated technology that could help sidestep key safety issues with conventional delivery methods.
